VectivBio Holding AG
VECT · NASDAQ
12/31/2022 | 6/30/2022 | 12/31/2021 | 6/30/2021 | |
|---|---|---|---|---|
| Revenue | $676 | $26,665 | $0 | $0 |
| % Growth | -97.5% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $676 | $26,665 | $0 | $0 |
| % Margin | 100% | 100% | – | – |
| R&D Expenses | -$111,588 | $185,541 | $25,090 | $25,090 |
| G&A Expenses | $7,057 | $26,855 | $17,904 | $17,904 |
| SG&A Expenses | $7,057 | $26,855 | $17,904 | $17,904 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $64,490 | -$64,490 | -$86,448 | -$86,448 |
| Operating Expenses | -$40,041 | $147,906 | -$43,455 | -$43,455 |
| Operating Income | -$28,553 | -$51,971 | -$43,455 | -$43,455 |
| % Margin | -4,223.9% | -194.9% | – | – |
| Other Income/Exp. Net | -$93,708 | $80,604 | -$18 | -$18 |
| Pre-Tax Income | -$28,526 | -$65,102 | -$43,473 | -$43,473 |
| Tax Expense | -$48 | $155 | $32 | $32 |
| Net Income | -$28,478 | -$65,257 | -$43,505 | -$43,505 |
| % Margin | -4,212.8% | -244.7% | – | – |
| EPS | -0.65 | -1.47 | -1.62 | -1.62 |
| % Growth | 55.8% | 9.3% | 0% | – |
| EPS Diluted | -0.65 | -1.47 | -1.62 | -1.62 |
| Weighted Avg Shares Out | 44,127 | 44,127 | 26,957 | 26,957 |
| Weighted Avg Shares Out Dil | 44,127 | 44,127 | 26,957 | 26,957 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $676 | $0 | $0 |
| Interest Expense | -$27 | $3,191 | $18 | $18 |
| Depreciation & Amortization | -$88 | $764 | $59 | $59 |
| EBITDA | -$28,641 | -$51,207 | -$43,396 | -$43,396 |
| % Margin | -4,236.8% | -192% | – | – |